查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1926901

低功耗行动C型臂市场：按技术、应用和最终用户划分－2026年至2032年全球预测

Low Power Mobile C-arm Market by Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，低功耗行动 C 型臂市场价值将达到 11.9 亿美元，到 2026 年将成长到 12.8 亿美元，到 2032 年将达到 19.7 亿美元，年复合成长率为 7.42%。

关键市场统计数据
基准年 2025 11.9亿美元
预计年份：2026年 12.8亿美元
预测年份 2032 19.7亿美元
复合年增长率 (%) 7.42%

了解正在重塑现代医疗环境中低功耗行动 C 型臂应用的临床背景、采购重点和技术预期。

本执行摘要概述了低功耗移动式C臂在现代临床工作流程中不断演变的角色，并重点介绍了技术进步和医疗服务模式的变革如何重塑采购和使用模式。讨论首先从临床因素入手：微创手术、床边介入治疗以及在传统手术室外进行的手术的兴起，推动了对紧凑型、低剂量成像解决方案的需求。同时，临床医生也在寻求能够兼顾影像品质和移动性的系统，以支援患者快速週转、缩短手术时间并提高患者吞吐量。

说明技术、临床工作流程和服务模式的变革如何从根本上改变移动式 C 型臂供应商的采购标准和竞争地位

技术创新和医疗服务模式的转变正在改变行动C臂的竞争格局。平板检测器和先进影像处理演算法的进步正逐步缩小携带式和固定式成像系统之间的性能差距，使临床医生能够以更小的面积和更低的电力消耗进行更复杂的介入手术。同时，电池系统和轻质材料的进步使得手术过程中的重新定位更加快速流畅，从而在门诊、床边和混合手术环境中催生了新的工作流程。

评估美国新关税如何影响移动式C臂相关人员的采购选择、总到岸成本和采购风险管理

近期关税调整对诊断成像设备的製造商、经销商和最终用户产生了许多实际影响。部分进口零件和成品关税的提高，促使原始设备製造商 (OEM) 重新评估其筹资策略，重新审查供应商合同，并儘可能在本地采购关键子系统。这些调整促使在地采购计画更加重视总到岸成本、供应链韧性以及合约柔软性，以应对关税波动和海关清关时间的变化。

将应用主导的需求、最终用户优先事项和技术平台差异转化为产品和采购团队可以利用的细分洞察

从应用角度来看，产品需求差异显着。牙科手术设备必须优先考虑面积小巧、操作简单以及在重复性低能量成像中实现高剂量效率。而一般外科手术则需要灵活的定位和快速的影像撷取，以支援术中决策。整形外科应用尤其需要高解析度影像和透视连续性，以支持关节重建、脊椎和创伤手术。即使在脊椎手术中，由于解剖结构和手术入路的不同，颈椎和腰椎手术也需要不同的影像策略。疼痛管理应用则优先考虑精准的针头导引、低剂量透视以及易于定位，以适应重复性的门诊手术。

分析区域采购趋势、监管差异和服务需求，以了解影响全球医疗保健市场设备选择和采用的因素

区域趋势对低功耗移动式C型臂的需求和部署策略均有显着影响。在美洲，私人医院的投资週期以及门诊中心的扩张往往会影响采购决策，这表明市场对整合服务产品和融资模式有着浓厚的兴趣，这些产品和服务能够支援快速部署，同时又不影响全生命週期支援。同时，欧洲、中东和非洲地区的情况则更为复杂，监管协调、不同的报销模式以及医院基础设施能力的差异迫使供应商提供客製化的配置和针对特定区域的培训项目，以确保产品能够在不同的市场顺利部署。

分析竞争对手如何结合技术差异化、服务产品和通路伙伴关係，以确保长期临床应用和生命週期价值。

低功耗移动式C臂机的竞争动态日益受到产品创新和服务能力的双重驱动。一些製造商主要依靠技术差异化竞争，透过强调检测器性能、先进的影像处理技术和符合人体工学的设计来吸引临床要求较高的专科医生。另一些製造商则专注于整合服务模式，将预防性保养、软体更新、培训和备件等服务打包到可预测的营运合约中，从而减轻医院采购部门的行政负担。

为供应商和买家製定优先且可行的策略，以增强设备在整个生命週期中的韧性、临床整合和服务主导的差异化优势。

供应商应优先投资于可互通软体和远距离诊断，以减少停机时间和提升产品全生命週期价值，从而实现差异化竞争。製造商与其仅在初始价格上竞争，不如建立模组化升级路径和清晰的服务等级协定 (SLA)，这样可以使产品蓝图与医院预算保持一致，并帮助临床团队规划逐步的功能增强。此外，为关键零件建立检验的近岸外包或双重采购安排，有助于在维持品管的同时，减轻贸易和关税波动对生产计画的影响。

我们将解释支撑这项分析和策略建议的多源调查方法、专家检验过程和数据三角测量技术。

我们的研究途径包括对临床负责人、生物医学工程经理、采购专业人员和设备服务专家进行初步访谈，以全面观点使用模式、维护负担和采购重点。除了这些定性见解外，我们还对成像平台进行了技术评估，对检测器技术进行了比较分析，并分析了监管要求和相关文件，以确保充分体现临床视角和合规要求。

总结临床需求、设备功能和策略采购选择如何相互作用，从而决定移动式C臂的长期临床和营运价值。

微创手术的临床需求不断增长，加之检测器技术和设备人体工学的进步，使得低功耗移动式C臂的实际应用范围不断扩大，涵盖了更广泛的医疗环境。因此，采购决策也从简单的商品采购演变为需要临床、技术和财务等各相关人员通力合作的策略投资。能够提供互操作系统、完善的服务网路和清晰升级路径的供应商，将在竞争激烈的采购过程中脱颖而出。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 低功耗移动C臂市场（依技术划分）

  • 平板检测器
  • 影像增强器

9. 低功耗移动C臂市场（按应用划分）

  • 牙科
  • 一般外科
  • 整形外科
    • 关节重建
    • 脊椎手术
      • 颈椎
      • 腰部
    • 创伤外科
  • 疼痛管理

第十章 低功耗行动C臂市场（依最终用户划分）

  • 门诊手术中心
  • 牙医诊所
  • 医院
    • 当地医疗机构
    • 三级医疗
  • 整形外科诊所
  • 疼痛管理诊所

第十一章 低功率移动式C臂市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章 低功耗行动C臂市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章 各国低功耗移动式C臂市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

14. 美国低功耗行动C臂市场

第十五章 中国的低功耗行动C臂市场

第十六章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Analogic Corporation
  • Canon Medical Systems Corporation
  • DMS Group
  • DRGEM Co., Ltd.
  • General Electric Company
  • Hologic, Inc.
  • Koninklijke Philips NV
  • OrthoScan, Inc.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • SternMed GmbH
  • Ziehm Imaging GmbH
Product Code: MRR-4F7A6D4FF368

The Low Power Mobile C-arm Market was valued at USD 1.19 billion in 2025 and is projected to grow to USD 1.28 billion in 2026, with a CAGR of 7.42%, reaching USD 1.97 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.19 billion
Estimated Year [2026] USD 1.28 billion
Forecast Year [2032] USD 1.97 billion
CAGR (%) 7.42%

Introducing the clinical context, procurement priorities, and technological expectations that are reshaping adoption of low power mobile C-arms across modern care environments

This executive summary frames the evolving role of low power mobile C-arms within contemporary clinical workflows, highlighting how technological refinements and changing care delivery models are reshaping procurement and usage patterns. The discussion opens with clinical drivers: minimally invasive procedures, point-of-care interventions, and the increasing volume of procedures taking place outside traditional operating rooms are accentuating demand for compact, lower-dose imaging solutions. In parallel, clinicians are seeking systems that strike a balance between image quality and maneuverability to support rapid turnover, shorter procedure times, and enhanced patient throughput.

From an operational perspective, hospital imaging teams and ambulatory surgery centers are prioritizing devices that reduce total cost of ownership through simplified maintenance, modular serviceability, and robust remote diagnostics. As a result, manufacturers are directing design efforts toward streamlined user interfaces, intuitive positioning aids, and integrated dose-management features. These advances dovetail with regulatory emphasis on patient safety and radiation stewardship, prompting buyers to weigh compliance capabilities as heavily as image performance.

Taken together, these clinical and operational dynamics are creating new expectations for mobile C-arms: devices must be agile enough for point-of-care settings, mature enough to meet surgical imaging demands, and economically sustainable across diverse care environments. The following sections analyze the strategic inflection points, regulatory and trade-related pressures, customer segmentation nuances, and regional considerations that decision-makers should factor into procurement and deployment strategies.

Explaining the technological, clinical workflow, and service model shifts that are fundamentally altering purchasing criteria and competitive positioning for mobile C-arm suppliers

A confluence of technological improvements and care-delivery shifts has altered the competitive landscape for mobile C-arms. Flat panel detectors and advanced image processing algorithms have progressively closed the gap between portable and fixed imaging systems, enabling clinicians to perform increasingly complex interventions with devices that occupy a fraction of floor space and power budget. At the same time, advances in battery systems and lightweight materials have made intra-procedural repositioning quicker and less disruptive, unlocking new workflows in ambulatory, bedside, and hybrid settings.

Concurrently, clinical practice is moving toward minimally invasive and image-guided procedures across orthopedics, spinal care, and pain management, which places a premium on real-time imaging fidelity and radiation optimization. This trend is motivating manufacturers to embed features such as dose-monitoring dashboards and automated exposure controls, thereby aligning product roadmaps with clinician priorities for safety and efficiency. As a result, purchasing committees are increasingly cross-functional, involving surgeons, radiology technologists, biomedical engineering teams, and finance partners to evaluate devices against a broader set of clinical and operational criteria.

Finally, digital transformation is injecting new expectations around interoperability, remote serviceability, and data analytics. Stakeholders now expect imaging equipment to integrate seamlessly with hospital information systems, support image export to PACS and cloud repositories, and enable remote diagnostics to minimize downtime. Taken together, these transformative shifts require suppliers to offer not only hardware improvements but also software-enabled service models, training programs, and lifecycle partnerships that support long-term clinical adoption and institutional objectives.

Evaluating how new United States tariff measures are reshaping sourcing choices, total landed costs, and procurement risk management for mobile C-arm stakeholders

Recent tariff changes have introduced a range of practical consequences for manufacturers, distributors, and end users of imaging equipment. Increased duties on certain imported components and finished devices have prompted original equipment manufacturers to revisit sourcing strategies, re-evaluate supplier contracts, and pursue localization for critical subsystems where feasible. These adjustments have, in turn, impacted procurement planning by creating greater emphasis on total landed cost, supply chain resilience, and contractual flexibility to accommodate variable duties and customs processing timelines.

In response, some suppliers have shifted to dual-sourcing models and nearshoring arrangements to mitigate exposure to trade policy volatility. These moves often require short lead-time suppliers with validated quality systems and regulatory-compliant manufacturing processes, and they may necessitate additional capital investment to qualify new production partners. For health systems and device purchasers, the consequence is that procurement cycles increasingly factor in supplier geographic diversity and contractual protections such as long-term pricing clauses and expedited replacement guarantees.

Moreover, tariff-driven cost pressures are accelerating discussions about value-based procurement, extended warranties, and service bundling as mechanisms to control lifecycle costs. Hospitals and ambulatory centers are scrutinizing total ownership considerations and favoring suppliers that can demonstrate dependable spare parts availability, transparent cost structures, and strong after-sales support. Collectively, these dynamics are encouraging a more strategic, partnership-oriented procurement posture that balances cost, continuity of care, and rapid access to critical imaging assets.

Translating application-driven requirements, end user priorities, and technology platform differences into actionable segmentation insights for product and procurement teams

When viewed through application lenses, product requirements diverge notably. Devices intended for dental procedures must prioritize compact footprints, simplified controls, and dose efficiency for repetitive, low-energy imaging, whereas general surgery applications require flexible positioning and rapid image acquisition to support intraoperative decision-making. Orthopedic use cases drive distinct demands for high-resolution imaging and fluoroscopic continuity to support joint replacement, spinal surgery, and trauma surgery; within spinal surgery, differentiated imaging strategies are required for cervical procedures versus lumbar interventions due to anatomical and operative access considerations. Pain management applications prioritize precise needle guidance, low-dose fluoroscopy, and ease of repositioning for repeated outpatient procedures.

End user contexts impose further nuance on procurement and deployment. Ambulatory surgery centers and dental clinics favor systems that minimize footprint, require limited infrastructure changes, and offer straightforward service contracts. Hospitals, which can be community-level hospitals or tertiary care centers, evaluate devices against broader interoperability, high-utilization durability, and advanced functionality for complex procedures. Orthopedic clinics and dedicated pain management clinics tend to emphasize specialized imaging features and service responsiveness that support high procedure volumes and rapid patient throughput.

On the technology front, the choice between flat panel detector systems and image intensifier architectures remains a defining performance tradeoff. Flat panel detectors deliver superior image uniformity, enhanced post-processing capabilities, and often lower maintenance profiles, while image intensifiers can offer cost advantages and proven reliability in certain clinical workflows. Suppliers and purchasers alike must align technology selection with procedural mix, training capacity, and anticipated lifecycle service needs to ensure clinical efficacy and operational sustainability.

Unpacking regional procurement dynamics, regulatory nuances, and service requirements that influence device selection and implementation across global healthcare markets

Regional dynamics exert a strong influence on both demand and deployment strategies for low power mobile C-arms. In the Americas, purchasing decisions are frequently shaped by a combination of private hospital investment cycles and ambulatory center expansion; this region shows strong interest in integrated service offerings and financing models that support rapid acquisition without compromising lifecycle support. Moving from there, Europe, Middle East & Africa presents a heterogeneous landscape where regulatory harmonization, variable reimbursement models, and differing hospital infrastructure capabilities require suppliers to offer tailored configurations and localized training programs to achieve adoption across disparate markets.

Asia-Pacific is characterized by rapid capacity expansion in both public and private healthcare sectors, paired with an appetite for scalable, cost-efficient imaging solutions that can be deployed across a wide range of clinical settings. Within each region, local regulatory pathways and certification requirements influence time-to-deployment and the scope of clinical validation needed for devices, which in turn affect supplier go-to-market sequencing and resource allocation. Furthermore, cross-border service considerations such as spare parts logistics, in-region technical training, and remote support capabilities shape long-term service commitments and influence buyer preferences for manufacturers with established regional footprints.

Taken together, these regional considerations suggest that suppliers and purchasers should adopt differentiated strategies that reflect local reimbursement environments, regulatory regimes, and the maturity of surgical and imaging infrastructure to maximize clinical impact and operational efficiency.

Profiling how competitors are combining technological differentiation, service delivery, and channel partnerships to secure long-term clinical adoption and lifecycle value

Competitive dynamics in the low power mobile C-arm sector are increasingly driven by the combination of product innovation and service capability. Some manufacturers are competing primarily on technological differentiation, emphasizing detector performance, advanced image processing, and ergonomic design to appeal to clinically demanding specialties. Others are leaning into integrated service models that bundle preventative maintenance, software updates, training, and spare parts into predictable operating contracts that reduce administrative burden for hospital procurement teams.

Strategic partnerships and channel diversification are common approaches to broaden geographic reach while managing capital intensity. Distributors and independent service organizations play a material role in enabling manufacturers to extend localized support, particularly in regions where direct presence is limited. For buyers, the presence of a robust service network often outweighs marginal differences in technical specifications, since uptime and rapid access to parts and technicians directly affect clinical throughput and patient care continuity.

Finally, product portfolios are being shaped by lifecycle management strategies that include modular upgrades, software-driven feature enhancements, and cross-compatible accessories to extend device utility. These approaches enable suppliers to maintain longer customer relationships, create upgrade pathways that align with hospital budgeting cycles, and provide demonstrable value through incremental performance improvements rather than frequent hardware replacements.

Prioritized, implementable strategies for suppliers and buyers to enhance device resilience, clinical integration, and service-driven differentiation across the lifecycle

Suppliers should prioritize investment in interoperable software and remote diagnostics to reduce downtime and differentiate on total lifecycle value rather than solely on upfront price. By developing modular upgrade paths and clear service-level agreements, manufacturers can align product roadmaps with institutional budgeting horizons and help clinical teams plan for incremental capability additions. In addition, establishing validated nearshoring or dual-sourcing arrangements for critical components can insulate production timelines from trade and tariff volatility while preserving quality control.

Healthcare providers should adopt cross-functional evaluation teams that include clinical, biomedical engineering, and supply chain stakeholders to assess devices against a balanced set of criteria: procedural fit, training requirements, service responsiveness, and long-term maintainability. Procuring entities can also negotiate outcome-oriented service contracts and prioritized spare parts agreements to ensure continuity of care. For distributors and channel partners, building technical training programs and localized maintenance hubs will strengthen value propositions in regionally diverse markets and support faster deployment cycles.

Across the ecosystem, stakeholders should also invest in clinician training and standardized protocols to ensure consistent image acquisition practices and radiation safety. These investments enhance clinical confidence, reduce variation in outcomes, and support broader adoption. By executing on these prioritized actions, organizations can improve operational resilience, accelerate technology adoption where clinically warranted, and create durable competitive advantages rooted in service excellence and clinical alignment.

Explaining the multi-source research methodology, expert validation processes, and data triangulation techniques that underpinned the analysis and strategic recommendations

The research approach combined primary interviews with clinical leaders, biomedical engineering managers, procurement professionals, and device service specialists to capture a holistic perspective on usage patterns, maintenance burdens, and purchasing priorities. These qualitative inputs were complemented by technical assessments of imaging platforms, comparative reviews of detector technologies, and analysis of regulatory requirements and documentation to ensure clinical and compliance considerations were thoroughly represented.

To validate findings, multiple data streams were triangulated: interview-derived insights were cross-checked against device specification sheets, service literature, and clinical procedure protocols. Where applicable, anonymized operational metrics such as utilization patterns, maintenance turnaround times, and downtime reports were reviewed to corroborate practitioner feedback. Regional regulatory reviews and trade-policy analyses were also incorporated to contextualize supply chain and procurement implications.

Finally, iterative expert reviews with independent clinicians and technical advisors were conducted to refine interpretations and ensure the practical applicability of recommendations. This layered methodology supports robust, decision-relevant insights while aligning research outputs with the informational needs of clinical leaders, procurement teams, and product strategists.

Summarizing how clinical imperatives, device capabilities, and strategic procurement choices intersect to determine the long-term clinical and operational value of mobile C-arms

Emerging clinical demands for minimally invasive procedures, combined with improvements in detector technology and device ergonomics, are expanding the practical applications for low power mobile C-arms across a wider array of care settings. Procurement decisions are therefore evolving from commodity purchases into strategic investments that require alignment across clinical, technical, and financial stakeholders. Suppliers that respond with interoperable systems, robust service networks, and clear upgrade pathways will be advantaged in competitive procurement processes.

Trade policy shifts and regional regulatory nuances add complexity to sourcing and deployment, underscoring the need for flexible supply chains and service models that can adapt to variable duty structures and localized certification requirements. Ultimately, success will hinge on partnerships that balance device capability with predictable lifecycle support, clinician training, and data-enabled performance management. By prioritizing these elements, decision-makers can ensure that imaging investments deliver sustained clinical value, operational resilience, and improved patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Low Power Mobile C-arm Market, by Technology

  • 8.1. Flat Panel Detector
  • 8.2. Image Intensifier

9. Low Power Mobile C-arm Market, by Application

  • 9.1. Dental
  • 9.2. General Surgery
  • 9.3. Orthopedic
    • 9.3.1. Joint Replacement
    • 9.3.2. Spinal Surgery
      • 9.3.2.1. Cervical
      • 9.3.2.2. Lumbar
    • 9.3.3. Trauma Surgery
  • 9.4. Pain Management

10. Low Power Mobile C-arm Market, by End User

  • 10.1. Ambulatory Surgery Centers
  • 10.2. Dental Clinics
  • 10.3. Hospitals
    • 10.3.1. Community
    • 10.3.2. Tertiary Care
  • 10.4. Orthopedic Clinics
  • 10.5. Pain Management Clinics

11. Low Power Mobile C-arm Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Low Power Mobile C-arm Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Low Power Mobile C-arm Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Low Power Mobile C-arm Market

15. China Low Power Mobile C-arm Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Analogic Corporation
  • 16.6. Canon Medical Systems Corporation
  • 16.7. DMS Group
  • 16.8. DRGEM Co., Ltd.
  • 16.9. General Electric Company
  • 16.10. Hologic, Inc.
  • 16.11. Koninklijke Philips N.V.
  • 16.12. OrthoScan, Inc.
  • 16.13. Shimadzu Corporation
  • 16.14. Siemens Healthineers AG
  • 16.15. SternMed GmbH
  • 16.16. Ziehm Imaging GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LOW POWER MOBILE C-ARM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LOW POWER MOBILE C-ARM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES LOW POWER MOBILE C-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA LOW POWER MOBILE C-ARM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY FLAT PANEL DETECTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY FLAT PANEL DETECTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY FLAT PANEL DETECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY IMAGE INTENSIFIER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY IMAGE INTENSIFIER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY IMAGE INTENSIFIER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY JOINT REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY JOINT REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY CERVICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY CERVICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY CERVICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY LUMBAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY LUMBAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY LUMBAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY TRAUMA SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY TRAUMA SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY TRAUMA SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY COMMUNITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY COMMUNITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY COMMUNITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY TERTIARY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY PAIN MANAGEMENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY PAIN MANAGEMENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY PAIN MANAGEMENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS LOW POWER MOBILE C-ARM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 127. GCC LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. GCC LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. GCC LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 131. GCC LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. GCC LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 148. G7 LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. G7 LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. G7 LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 152. G7 LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 153. G7 LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. G7 LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 155. NATO LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. NATO LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. NATO LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 159. NATO LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 160. NATO LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. NATO LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL LOW POWER MOBILE C-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES LOW POWER MOBILE C-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA LOW POWER MOBILE C-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA LOW POWER MOBILE C-ARM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA LOW POWER MOBILE C-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA LOW POWER MOBILE C-ARM MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA LOW POWER MOBILE C-ARM MARKET SIZE, BY SPINAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA LOW POWER MOBILE C-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA LOW POWER MOBILE C-ARM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)